Skip to main navigation Skip to search Skip to main content

Corrigendum to “Caspofungin salvage therapy in Pneumocystis jirovecii pneumonia” (Caspofungin salvage therapy in Pneumocystis jirovecii pneumonia (2017) 50(4) (547–548), (S1684118216300299), (10.1016/j.jmii.2016.03.008))

Research output: Contribution to journalErratumpeer-review

Abstract

This article has a mistake.

Original languageEnglish
Pages (from-to)510
Number of pages1
JournalJournal of Microbiology, Immunology and Infection
Volume52
Issue number3
DOIs
Publication statusPublished - Jun 2019

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

ASJC Scopus subject areas

  • Immunology and Allergy
  • General Immunology and Microbiology
  • Microbiology (medical)
  • Infectious Diseases

Fingerprint

Dive into the research topics of 'Corrigendum to “Caspofungin salvage therapy in Pneumocystis jirovecii pneumonia” (Caspofungin salvage therapy in Pneumocystis jirovecii pneumonia (2017) 50(4) (547–548), (S1684118216300299), (10.1016/j.jmii.2016.03.008))'. Together they form a unique fingerprint.

Cite this